Great time to load up nowafter they resubmit the N

Great time to load up nowafter they resubmit the NDA for Rizaport early this week .GL

RedHill Biopharma and IntelGenx Submit New Drug Application to FDA for RIZAPORT® for Migraines..November 1, 2017
https://finance.yahoo.com/news/redhill-biopha...00087.html


Market Cap : US$48 Million / Cash US$8.2 million /very low burn-rate of ~$700K a Quarter =Cash untill 2020+ EXCLUDING payments from new partnerships ,profitability expected quickly with approval for Rizaport and Tadalafil both approval expected in 2018, if everything goes well then this stock could run to $10 even then it wouldnt be expensive .


Intelgenx (IGXT)

Markt-Cap $48 Million
Cash 8.1 Million
Price: $0.73


FDA Decision for Rizaport(Migraine) in Q2/2018 (Peak Sales $60-80 Million)


NDA submission for Tadalafil (erectile dysfunction) this Quarter >> FDA approval in 2H 2018 (Peak Sales $150++ Million)


Start Phase 2a for Montulukast (Alzheimer disease) this Quarter >> Phase 2a Results in 1H/2018 (Potential BLOCKBUSTER Drug)


Opioid dependence drug partnered with Par Pharma >> FDA approval depends on patent ruling (Peak Sales $100++ Million) 30-Month Stay already expired



MEGA Pipeline
http://s2.q4cdn.com/790425727/files/images/20...y-2017.jpg


Presentation
http://s2.q4cdn.com/790425727/files/doc_prese..._final.pdf


https://investorintel.com/sectors/biotech/bio...lm-market/